Cite

HARVARD Citation

    Werzowa, J. et al. (2015). Prophylactic CMV therapy does not improve three‐yr patient and graft survival compared to preemptive therapy. Clinical transplantation. pp. 1230-1238. [Online]. 
  
Back to record